CN101849985B - Chinese medicament for treating tachycardia - Google Patents
Chinese medicament for treating tachycardia Download PDFInfo
- Publication number
- CN101849985B CN101849985B CN2009102358782A CN200910235878A CN101849985B CN 101849985 B CN101849985 B CN 101849985B CN 2009102358782 A CN2009102358782 A CN 2009102358782A CN 200910235878 A CN200910235878 A CN 200910235878A CN 101849985 B CN101849985 B CN 101849985B
- Authority
- CN
- China
- Prior art keywords
- chinese medicine
- chinese medicament
- fine powder
- chinese
- make
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a Chinese medicament for treating tachycardia, and belongs to the field of Chinese medicaments for treating cardiovascular and cerebrovascular system diseases. The Chinese medicament aims to have good effect and quick response. The Chinese medicament is prepared from raw materials such as rosewood heart wood, glossy ganoderma, radix pseudo-ginseng and szechuan lovage rhizome. The Chinese medicament has the effects of strengthening body resistance and archaeus, supplementing qi and nourishing blood, promoting blood circulation by removing blood stasis and invigorating circulation, and has the advantages of obvious effect, definite curative effect and quick response.
Description
Technical field
The invention belongs to the field of Chinese medicines of treatment diseases of cardiovascular and cerebrovascular systems.
Background technology
Be intended at present treat the tachycardic field of Chinese medicines, come with some shortcomings: the one, effect is obvious inadequately, and the 2nd, it is slower to take effect.So that many tachycardic middle-aged and elderly people are had palpitation for a long time, the torment of cardiopalmus, uncomfortable in chest, tachycardia, had a strong impact on quality of life, patient and family members thereof are satisfied inadequately to this.
At problem set forth above, the invention provides the tachycardic Chinese medicine of a kind of treatment, it can solve, and this type of Chinese medicine effect was obvious inadequately in the past, the slower problem that takes effect, effective, instant effect, it is remarkable to have effect, and drug effect is definite, the advantage of quick result.
Summary of the invention
The present invention is achieved through the following technical solutions:
1, the tachycardic Chinese medicine of a kind of treatment adopts the raw material of Chinese medicine preparation, and filling a prescription is (by weight):
Lignum Dalbergiae Odoriferae 3-20 part Ganoderma 2-12 part Radix Notoginseng 3-20 part
Rhizoma Chuanxiong 4-30 part
The tachycardic Chinese medicine of this treatment is made by following method:
(1) by above-mentioned weight ratio, Lignum Dalbergiae Odoriferae, Rhizoma Chuanxiong are extracted through conventional water extraction process, make the extractum fine powder;
(2) by above-mentioned weight ratio, Ganoderma, Radix Notoginseng are ground into fine powder respectively, mix, stir with above-mentioned extractum fine powder; As required, can be made into Chinese medicine electuary, granule, powder, capsule, watered pill, tablets and other formulations.
The present invention is according to the folk tradition prescription, and the theory according to traditional Chinese medical science the body resistance strengthening and constitution consolidating, blood circulation promoting and blood stasis dispelling develops meticulously.Ganoderma benefiting QI and nourishing blood in the side, tranquilizing by nourishing the heart, the body resistance strengthening and constitution consolidating, enhancing human body immunity power; Rhizoma Chuanxiong, Radix Notoginseng nourshing blood and promoting blood circulation, blood-activating analgetic; The Lignum Dalbergiae Odoriferae temperature is current to stagnate, disperse blood stasis and dredge collateral peace arteries and veins.All medicine compatibilities bring out the best in each other, and play the body resistance strengthening and constitution consolidating altogether, and the merit that benefiting QI and nourishing blood, blood circulation promoting and blood stasis dispelling are promoted blood circulation is effective, instant effect, and it is remarkable to have effect, and drug effect is definite, the advantage of quick result.
The specific embodiment
By following embodiment the present invention is done and to specify:
1, get following prescription (weight is unit by gram):
Lignum Dalbergiae Odoriferae 60 kairine sesames 40 gram Radix Notoginseng 60 grams
Rhizoma Chuanxiong 80 grams
Weight in accordance with regulations, with conventional water extraction process Lignum Dalbergiae Odoriferae, Rhizoma Chuanxiong are extracted, make extractum fine powder 42 grams, Ganoderma, Radix Notoginseng are ground into fine powder respectively, mix, stir with above-mentioned extractum fine powder, make fine particle, the capsule of packing into No. 0 is made 507 of Chinese medicinal capsules, and every capsules includes Chinese medicine fine powder and extract 0.28 gram.
2, get following prescription (weight is unit by gram):
Lignum Dalbergiae Odoriferae 100 kairine sesames 60 gram Radix Notoginseng 100 grams
Rhizoma Chuanxiong 160 grams
By above-mentioned same method, make 850 of Chinese medicinal capsules, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
3, get following prescription (weight is unit by gram):
Lignum Dalbergiae Odoriferae 200 kairine sesames 120 gram Radix Notoginseng 200 grams
Rhizoma Chuanxiong 300 grams
By above-mentioned same method, make 1678 of Chinese medicinal capsules, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
4, get following prescription (by weight):
6 parts of 4 portions of Radix Notoginseng of 6 portions of Ganodermas of Lignum Dalbergiae Odoriferae
8 parts of Rhizoma Chuanxiongs
By above-mentioned same method, make Chinese medicinal capsule, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
5, get following prescription (by weight):
15 parts of 8 portions of Radix Notoginseng of 15 portions of Ganodermas of Lignum Dalbergiae Odoriferae
25 parts of Rhizoma Chuanxiongs
By above-mentioned same method, make Chinese medicinal capsule, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
Clinical data:
The present invention is an example with traditional Chinese medical science tachycardia, through 8 routine clinical observations.Selecting tcm diagnosis cardiopalmus, tachycardia is standard: pulse is too fast during outbreak, nervous mental confusion, and feeling of distension and oppression over the chest, extremity are numb, and limb is soft weak, heart rate about 160 times/minute.As above symptom can be made a definite diagnosis.In making a definite diagnosis the object of observation, male's 5 examples, women's 3 examples do not have other serious disease, and the age is 41 years old-80 years old, 64.2 years old mean age.
Efficacy determination:
1, produce effects: body constitution strengthens, extremity energetically, cardiac distresses such as nervous cardiopalmus are obviously alleviated or are disappeared, heart district is comfortable, heart rate is below 100 times/minute.
2, effective: body constitution strengthens, and cardiac distresses such as nervous cardiopalmus are alleviated to some extent.
3, invalid: the disease no change.
During clinical experiment, withdraw other medicines and health nutrient.Taking Chinese medicinal capsule of the present invention, observed 3 months, is a course of treatment.Instructions of taking: every day 2 times, each 4 capsules, every capsules include Chinese medicine fine powder and extract 0.28 gram, warm water delivery service after meal, symptom promptly has alleviation after 30 days, take 3 months after, symptom is obviously improved.8 philtrums of clinical experiment, produce effects 4 people, effective 3 people, invalid 1 people, total effective rate 87.5%.
Claims (1)
1. the tachycardic Chinese medicine of treatment adopts the raw material of Chinese medicine preparation, it is characterized in that it is to make with the component of following weight ratio
Lignum Dalbergiae Odoriferae 3-20 part Ganoderma 2-12 part Radix Notoginseng 3-20 part
Rhizoma Chuanxiong 4-30 part
The tachycardic Chinese medicine of this treatment is made by following method:
(1) by above-mentioned weight ratio, Lignum Dalbergiae Odoriferae, Rhizoma Chuanxiong are extracted through conventional water extraction process, make the extractum fine powder;
(2) by above-mentioned weight ratio, Ganoderma, Radix Notoginseng are ground into fine powder respectively, mix, stir with above-mentioned extractum fine powder; Make Chinese medicine granules, powder, capsule, watered pill, tablet.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2009102358782A CN101849985B (en) | 2009-10-28 | 2009-10-28 | Chinese medicament for treating tachycardia |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2009102358782A CN101849985B (en) | 2009-10-28 | 2009-10-28 | Chinese medicament for treating tachycardia |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101849985A CN101849985A (en) | 2010-10-06 |
| CN101849985B true CN101849985B (en) | 2011-06-29 |
Family
ID=42801774
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2009102358782A Expired - Fee Related CN101849985B (en) | 2009-10-28 | 2009-10-28 | Chinese medicament for treating tachycardia |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101849985B (en) |
-
2009
- 2009-10-28 CN CN2009102358782A patent/CN101849985B/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CN101849985A (en) | 2010-10-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101843661B (en) | Chinese medicament for treating angina | |
| CN101843660B (en) | Chinese medicament for treating tachycardia | |
| CN101843712B (en) | Chinese medicament for treating angina | |
| CN101843644B (en) | Chinese medicament for treating tachycardia | |
| CN101849985B (en) | Chinese medicament for treating tachycardia | |
| CN101843753B (en) | Chinese medicament for treating angina | |
| CN101843717B (en) | Chinese medicament for treating coronary disease | |
| CN101850055B (en) | Chinese medicament for treating coronary heart diseases | |
| CN101843645B (en) | Chinese medicament for treating tachycardia | |
| CN101843793B (en) | Chinese medicament for treating tachycardia | |
| CN101843755A (en) | Chinese medicament for treating diabetic cardiopathy | |
| CN101843759B (en) | Oral Chinese medicament for treating fracture | |
| CN101843758B (en) | Chinese medicament for treating coronary disease | |
| CN101850034B (en) | Chinese medicament for treating angina | |
| CN101843647B (en) | Chinese medicament for treating angina | |
| CN101843720B (en) | Chinese medicament for treating angina | |
| CN101564476B (en) | Chinese medicament for treating coronary heart disease | |
| CN101843672B (en) | Chinese medicament for treating arteriosclerosis | |
| CN101843835B (en) | Chinese medicament for treating coronary diseases | |
| CN101843832B (en) | Chinese medicament for treating coronary disease | |
| CN101843673B (en) | Chinese medicament for treating arteriosclerosis | |
| CN101843700A (en) | Chinese medicament for treating coronary disease | |
| CN101843646A (en) | Chinese medicament for treating tachycardia | |
| CN101843792A (en) | Chinese medicament for treating angina | |
| CN101843730A (en) | Chinese medicament for treating coronary disease |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| ASS | Succession or assignment of patent right |
Owner name: RUGAO BINJIANG URBAN CONSTRUCTION INVESTMENT CO., Free format text: FORMER OWNER: BEIJING LVYUANQIUZHENG TECHNOLOGY DEVELOPMENT CO., LTD. Effective date: 20130701 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 100040 SHIJINGSHAN, BEIJING TO: 226500 NANTONG, JIANGSU PROVINCE |
|
| TR01 | Transfer of patent right |
Effective date of registration: 20130701 Address after: 226500 Rugao province Jiangsu City Jiangan Town Road No. 166. Patentee after: RUGAO BINJIANG URBAN CONSTRUCTION INVESTMENT CO., LTD. Address before: 100040 Beijing city Shijingshan District street Babaoshan Lugu Village District No. 7 building 10-602 room Patentee before: Beijing Lvyuanqiuzheng Technology Development Co., Ltd. |
|
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20110629 Termination date: 20151028 |
|
| EXPY | Termination of patent right or utility model |